Equity Mates Investing PodcastThe Inside Story of Eucalyptus: Tim Doyle on Starting, Scaling and Selling a $1.6 billion businessBattling Weight-Loss Drug Backlash
28:14–29:06 · 52s
Tim defends advertising GLP-1 medications, pushing back on critics who call the approach unethical and arguing the treatments are life-changing for patients.